IFX-1-P2.6: A randomized, double-blind, placebo-controlled, multicenter, parallel-group Phase II study toinvestigate the safety and efficacy of two different dose regimens of IFX-1 as add-on to standard of care insubjects with granulomatosis with polya

Project: Research project

Project Details

Description

IFX-1-P2.6: A randomized, double-blind, placebo-controlled, multicenter, parallel-group Phase II study to investigate the safety and efficacy of two different dose regimens of IFX-1 as add-on to standard of care in subjects with granulomatosis with polya
StatusActive
Effective start/end date6/1/1812/31/21

Funding

  • INFLARX GMBH

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.